What is Johnson & Johnson's innovative medicine — amortization?

Johnson & Johnson (JNJ) reported innovative medicine — amortization of $800.00M in Q1 2026.

How has Johnson & Johnson's innovative medicine — amortization changed year-over-year?

Johnson & Johnson's innovative medicine — amortization increased by 33.3% year-over-year, from $600.00M to $800.00M.

What does innovative medicine — amortization mean?

The non-cash expense related to the gradual write-down of acquired intangible assets like patents.

Innovative Medicine — Amortization

Johnson & Johnson Innovative Medicine — Amortization increased by 33.3% to $800.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 33.3%, from $600.00M to $800.00M.

Analysis

StatementSegment

CategoryEfficiency

SignalContext dependent

VolatilityStable

First reportedQ3 2022

Last reportedQ1 2026Apr 22, 2026

Rolls up toAdjustment for Amortization

How to read this metric

Higher amortization often reflects significant past M&A activity or heavy investment in intellectual property, while a decrease may suggest a maturing portfolio of assets.

Detailed definition

This represents the periodic expense recognized for the systematic allocation of the cost of finite-lived intangible ass...

Peer comparison

Standard across the pharmaceutical industry where M&A-driven intangible asset accumulation is common.

Metric ID: jnj_segment_innovative_medicine_amortization

Historical Data

11 periods

	Q3 '22	Q1 '23	Q2 '23	Q3 '23	Q1 '24	Q2 '24	Q3 '24	Q1 '25	Q2 '25	Q3 '25	Q1 '26
Value	$700.00M	$700.00M	$700.00M	$700.00M	$700.00M	$700.00M	$700.00M	$600.00M	$800.00M	$600.00M	$800.00M
QoQ Change	—	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	-14.3%	+33.3%	-25.0%	+33.3%
YoY Change	—	—	—	+0.0%	+0.0%	+0.0%	+0.0%	-14.3%	+14.3%	-14.3%	+33.3%

Range$600.00M – $800.00M

CAGR+5.5%

Avg YoY Growth+2.4%

Median YoY Growth+0.0%

Similar Metrics at Other Companies

Raymond James FinancialRJF View metric

DuPont de Nemours, Inc.DD View metric

Bristol-Myers SquibbBMY View metric

InsmedINSM View metric

Analog DevicesADI View metric

MarkelMKL View metric

Frequently Asked Questions

What is Johnson & Johnson's innovative medicine — amortization?: Johnson & Johnson (JNJ) reported innovative medicine — amortization of $800.00M in Q1 2026.
How has Johnson & Johnson's innovative medicine — amortization changed year-over-year?: Johnson & Johnson's innovative medicine — amortization increased by 33.3% year-over-year, from $600.00M to $800.00M.
What does innovative medicine — amortization mean?: The non-cash expense related to the gradual write-down of acquired intangible assets like patents.